Design, Synthesis and Biological Evaluation of Novel Pyrimido[4,5-d]pyrimidine CDK2 Inhibitors as Anti-tumor Agents
Open Access
- 1 January 2011
- journal article
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 79 (3) , 429-447
Abstract
A series of 2,5,7-trisubstituted pyrimido[4,5-d]pyrimidine cyclin-dependent kinase (CDK2) inhibitors is designed and synthesized. 6-Amino-2-thiouracil is reacted with an aldehyde and thiourea to prepare the pyrimido[4,5-d]-pyrimidines. Alkylation and amination of the latter ones give different amino derivatives. These compounds show potent and selective CDK inhibitory activities and inhibit in vitro cellular proliferation in cultured human tumor cells.Keywords
This publication has 19 references indexed in Scilit:
- Synthesis and biological evaluation of 3,6-disubstituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as a novel class of potential anti-tumor agentsEuropean Journal of Medicinal Chemistry, 2009
- Synthesis of quaternised 2-aminopyrimido[4,5-d]pyrimidin-4(3H)-ones and their biological activity with dihydrofolate reductaseEuropean Journal of Medicinal Chemistry, 2003
- A Convenient Synthesis and Hepatoprotective Activity of Imidazo[1,2-c]pyrimido[5,4-e]pyrimidine, Tetraazaacenaphthene and Tetraazaphenalene from Cyclic Ketene Aminals Through Tandem Addition-Cyclization ReactionsBioorganic & Medicinal Chemistry, 2002
- 1,4-Dioxane-fused 4-anilinoquinazoline as inhibitors of epidermal growth factor receptor kinaseArchiv der Pharmazie, 2001
- Inhibition of Herpes Simplex Virus Reactivation by DipyridamoleAntimicrobial Agents and Chemotherapy, 2001
- Mitotic kinases as regulators of cell division and its checkpointsNature Reviews Molecular Cell Biology, 2001
- Tyrosine Kinase Inhibitors. 12. Synthesis and Structure−Activity Relationships for 6-Substituted 4-(Phenylamino)pyrimido[5,4-d]pyrimidines Designed as Inhibitors of the Epidermal Growth Factor ReceptorJournal of Medicinal Chemistry, 1997
- Inhibition of human 5-phosphoribosyl-1-pyrophosphate synthetase by 4-amino-8-(beta-D-ribofuranosylamino)-pyrimido[5,4-d]pyrimidine-5'- monophosphate: evidence for interaction at the ADP allosteric site.Molecular Pharmacology, 1995
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990
- Antitumor and antiviral activity of synthetic .alpha.- and .beta.-ribonucleosides of certain substituted pyrimido[5,4-d]pyrimidines: a new synthetic strategy for exocyclic aminonucleosidesJournal of Medicinal Chemistry, 1989